Checkmate Pharmaceuticals, Inc. reported raising $10 Million in an initial SEC Form D filing, from an offering of $20 Million
Amount Raised
$10 Million
Round Type
Venture
CambridgeBiotechnologyHealthcareHealth CareScience And EngineeringWho else raised in Healthcare and Science And Engineering around the same time
Companies in the same sectors as Checkmate Pharmaceuticals, Inc. that raised within 45 days of this round, from Fundz verified event records.
- Strongbridge Biopharma plc raised $126M on September 14, 2015.
- Bigfoot Biomedical, Inc. raised $3.8M (Seed) on July 27, 2015.
- Strongbridge Biopharma plc raised $33M on July 17, 2015.
- CytoDyn raised $2.7M (Seed) on October 5, 2015.
- Deciphera Pharmaceuticals raised $22M on September 29, 2015.
- Corvus Pharmaceuticals, Inc. raised $75M on September 25, 2015.
Who to call at Checkmate Pharmaceuticals, Inc., and when
A new round usually means Checkmate Pharmaceuticals, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Checkmate Pharmaceuticals, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Checkmate Pharmaceuticals, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Checkmate Pharmaceuticals, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Checkmate Pharmaceuticals, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Checkmate Pharmaceuticals, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.